Minerva Neurosciences, Inc.

NASDAQ:NERV

Biotechnology

Healthcare
$2.18 -6.49%

-$0.30 today

Market cap
$108.64M
Beta
-0.11
P/E (TTM)
-0.2
EPS (TTM)
-$8.46
52W Low $1.76High $12.46

Volume 0.28M

Average 0.21M

NERV Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

Minerva Neurosciences, Inc.NASDAQ: NERV

Gross Margin · Q2 FY2026 · quarter ended Jun 2026

Gross margin not reported for Q2 FY2026

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
—— QoQ
Last fiscal yearDec 2025
—— YoY
LTMJun 2026
—— YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3 years———
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

No Gross Margin data reported for this period type.

Gross Margin vs competitors

How NERV compares with its peers on the latest reported figures

NERV Competitors Peer median
Gross Margin for NERV and competitors
Company Period LTM level YoY 3-year change
RLYBRallybio CorporationLTM Mar 202699.7% +7.2 pp—
NRXSNeurAxis, Inc.LTM Mar 202685.0% -0.8 pp-4.7 pp
NERVMinerva Neurosciences, Inc.FY2025— ——
ENLVEnlivex Therapeutics Ltd.FY2025— ——
Peer median (excluding NERV) 92.3%+3.2 pp-4.7 pp

Competitors are the stored peer set for NERV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue00000
Gross Profit00000
Gross Margin—————
Research & Development32.04M14.65M12.71M11.9M5.76M
Selling, General & Admin13.33M10.58M10.41M9.95M9.34M
Operating Expenses45.37M25.23M23.12M21.85M15.1M
Depreciation & Amortization101.79K8.51K30.98K22.47K5.44K
EBITDA(45.28M)(24.69M)(21.69M)6.02M(293.42M)
EBITDA Margin—————
Operating Income(45.37M)(25.23M)(23.12M)(21.85M)(15.1M)
Operating Margin—————
Interest Income16.52K556.95K1.44M1.27M948.12K
Interest Expense6.33M7.41M8.28M4.56M0
Other Income / Expenses(6.34M)(6.88M)(6.89M)23.29M(278.32M)
Income Before Tax(51.71M)(32.11M)(30.01M)1.44M(293.42M)
Pre-Tax Margin—————
Income Tax Expense(1.8M)0000
Net Income(49.91M)(32.11M)(30.01M)1.44M(293.42M)
Net Margin—————
EPS (Basic)(9.35)(6.01)(4.61)0.19(34.67)
EPS (Diluted)(9.35)(6.01)(4.61)0.19(34.67)
Weighted Avg Shares5.34M5.34M6.51M7.57M8.46M
Weighted Avg Shares (Diluted)5.34M5.34M6.51M7.57M8.46M

Minerva Neurosciences, Inc.

NASDAQ:NERV

Intrinsic Alpha fair value

Locked

Current Price

$2.18

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.